What Happened?
Santa Rosa, CA-based TriVascular has appointed Michael V. Chobotov as Chief Technology Officer.
About the Company
TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.
About the Person
Previously Choboto was Chief Executive Officer at TriVascular.
Info Source
News
Short Profile